DXCM
DexCom, Inc.
NASDAQ · USHealthcareMedical - Devices
$75.69-1.25%
Price as of Jul 20, 2026
DXCM capital
DexCom, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.47x
- Net debt / equity
- 0.09x
- Debt / assets
- 0.21x
- Debt / EBITDA
- 0.94x
- Net debt / EBITDA
- 0.18x
Liquidity & coverage
- Current ratio
- 1.95x
- Quick ratio
- 1.64x
- Cash ratio
- 1.09x
- Interest coverage
- 61.88x
- EBITDA / interest
- 88.39x
- Working capital
- $2.1B
Cash & dividend
- FCF / debt
- 1.03x
- Cash flow / debt
- 1.29x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.